EP-1366: Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC. (April 2018) - De Ruysscher, D.; Dingemans, A.; Praag, J.; Belderbos, J.; Tissing-Tan, C.; Herder, G.; Haitjema, T.; Ubbels, F.; Lagerwaard, F.; Stigt, J.; Smit, E.; Van Tinteren, H.; et al.